(PharmaNewsWire.Com, July 11, 2017 ) HAIs, which are also called nosocomial infections, refer to a collection of conditions that a patient may develop when being treated in hospitals or other healthcare facilities. Modern healthcare settings use multiple devices to treat patients. These can be breeding grounds for microorganisms, which can have adverse effects on patient health. HAIs have caused a significant cost burden on patients and healthcare facilities.
Publisher's analysts forecast the global hospital-acquired infection control market to grow at a CAGR of 4.81% during the period 2017-2021. For more information about this report: http://www.reportsweb.com/global-hospital-acquired-infection-control-market-2017-2021 . Covered in this report The report covers the present scenario and the growth prospects of the global hospital-acquired infection control market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of HAI products.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Hospital-Acquired Infection Control Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
